Loading…
Fund presentations, factsheets and reports, indexed by fund.
Browse the full index free. Opening the documents behind it is part of GREI Professional.
See plans2,427 documents·132 GP·560 LP·1,735 consultant
4 documents
Investment Committee informational staff report (File 23-114) on mid-year 2023 RE pacing update; reports one $10M Apollo life-science co-investment committed YTD against $100M budget.
Meketa Investment Group due-diligence summary memo on Ventas Life Science and Healthcare Real Estate Fund (VLSHREF), evaluating the core+ open-end vehicle for ERSRI's core real estate allocation. Dated February 22, 2023.
ERSRI staff recommendation memo approving up to $25M commitment to Ventas Life Science and Healthcare Real Estate Fund (VLSHREF), a core/core+ open-end fund focused on life science, medical office, and seniors housing. Meeting date March 22, 2023.
Ventas manager presentation for Rhode Island SIC on the Ventas Life Science and Healthcare Real Estate Fund, a core/core+ open-end fund targeting life science, medical office, and seniors housing assets in top U.S. cluster markets.
All materials are published by the firms or public bodies themselves; all rights remain with them. We link, we don’t rehost.